Invokana Recall Still Not In Sight

After 20 cases of ketoacidosis, Invokana is still on the market.

Invokana Recall still not in effectA few months ago (on May15th 2015 to be exact) the FDA warned that an new type of diabetes Type 2 drug; known as a SGLT2 inhibitor, sold under the name Invokana may be causing ketoacidosis in users.
Ketoacidosis is a liver disease which occurs when a patient gets too much acid in the blood. The most common symptoms of ketoacidosis include, nausea, vomiting, acute breathing difficulties, fuzziness in the brain or confusion, abdominal cramps and feeling unusually tired.
So far, the FDA said it received about 20 cases of ketoacidosis and all of these patients had to go to the hospital for treatment of the condition. Most patients took the drug for about 2 weeks before symptoms showed up.
What is amazing however is the fact that at the time of this writing (7 months later) no recall has been issued for this drug. There is a growing number of attorney websites looking for patients who have suffered after using Invokana. It is still unclear what is going to happen in the long run, but there is certainly cause for concern if you’ve used this drug.
On another note:
 By Maureen Salamon

HealthDay Reporter

SATURDAY, Nov. 7, 2015 (HealthDay News) — The rate of chronic kidney disease among Americans has leveled off over the last decade after climbing for many years, a new study found.

Researchers compared nationwide data for 2003-2004 and 2011-2012. Their study showed that the number of people with chronic kidney disease had stabilized or even decreased over the period. The plateau mirrors that found in U.S. cases of permanent kidney failure, also known as end-stage renal disease.

Credits: Kidney Disease Rates Have Stabilized in U.S., Study Finds


Related Post

It's only fair to share...Share on FacebookShare on Google+Tweet about this on TwitterPin on PinterestDigg this